Big Data in the Healthcare & Pharmaceutical Industry To Grow At A CAGR of More Than 15% By 2020

Big Data in the Healthcare & Pharmaceutical Industry Opportunities, Challenges, Strategies & Forecasts To 2030 | Hexa Reports

The “Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.

“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

Request A Sample copy of This Report @ http://www.hexareports.com/report/big-data-in-the-healthcare-and-pharmaceutical-industry-2017-2030/request-sample

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.

Browse Detail Report With TOC @ http://www.hexareports.com/report/big-data-in-the-healthcare-and-pharmaceutical-industry-2017-2030

Key Findings

The report has the following key findings:

  • In 2017, Big Data vendors will pocket nearly $4 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of more than 15% over the next three years, eventually accounting for over $5.8 Billion by the end of 2020.
  • Through the use of Big Data technologies, hospitals and other healthcare facilities have been able to achieve cost reductions of more than 10%, improvements in outcomes by as much as 20% for certain conditions, growth in revenue by 30%, and increase in patient access to services by more than 35%.
  • Big Data technologies are playing a pivotal role in accelerating the transition towards accountable and value-based care models, by enabling the continuous collection, consolidation and analysis of clinical and operational data from healthcare facilities and other available data sources.
  • Addressing privacy and security concerns is necessary in order to fully leverage the benefits of Big Data in the healthcare and pharmaceutical industry. Therefore, it is essential for key stakeholders to make significant investments in data encryption and cybersecurity, in addition to adopting defensible de-identification techniques and implementing strict restrictions on data use.

Key Questions Answered

The report provides answers to the following key questions:

  1. How big is the Big Data opportunity in the healthcare and pharmaceutical industry?
  2. How is the market evolving by segment and region?
  3. What will the market size be in 2020 and at what rate will it grow?
  4. What trends, challenges and barriers are influencing its growth?
  5. Who are the key Big Data software, hardware and services vendors and what are their strategies?
  6. How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?
  7. What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?
  8. Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?

Browse More Pharmaceuticals & Healthcare Related Market Research Reports:

• Global Collagen & Gelatin Industry 2018 Market Research Report –
http://www.hexareports.com/report/global-collagen-and-gelatin-industry-2018

• Global Artificial Vaginas Industry 2018 Market Research Report –
http://www.hexareports.com/report/global-artificial-vaginas-industry-2018

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:
Ryan Shaw
Hexa Reports
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com
Visit our Blog: http://hexareports.blogspot.com/

Matched content

Editor’s pick

Express Press Release Distribution